Spots Global Cancer Trial Database for inflammatory breast cancer stage iii
Every month we try and update this database with for inflammatory breast cancer stage iii cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
TRUDI: TDXD+Durva in HER2+/Low IBC | NCT05795101 | Invasive Breast... Inflammatory Br... HER2-positive B... HER2 Low Breast... Breast Cancer | Trastuzumab der... Durvalumab | 18 Years - | Dana-Farber Cancer Institute | |
TRUDI: TDXD+Durva in HER2+/Low IBC | NCT05795101 | Invasive Breast... Inflammatory Br... HER2-positive B... HER2 Low Breast... Breast Cancer | Trastuzumab der... Durvalumab | 18 Years - | Dana-Farber Cancer Institute |